These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30196731)

  • 21. New treatments for severe treatment-resistant asthma: targeting the right patient.
    Chung KF
    Lancet Respir Med; 2013 Oct; 1(8):639-652. PubMed ID: 24461667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study.
    Murray CS; Thomas M; Richardson K; Price DB; Turner SW
    J Allergy Clin Immunol Pract; 2017; 5(4):1082-1090.e7. PubMed ID: 28351789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and Management of Asthma in Adults: A Review.
    McCracken JL; Veeranki SP; Ameredes BT; Calhoun WJ
    JAMA; 2017 Jul; 318(3):279-290. PubMed ID: 28719697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.
    Tamimi A; Serdarevic D; Hanania NA
    Respir Med; 2012 Mar; 106(3):319-28. PubMed ID: 22196881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outpatient management of bronchial asthma in adults.
    Rosa JD; Chandy D; Aronow WS; DeLorenzo LJ
    Compr Ther; 2008; 34(1):10-7. PubMed ID: 18681106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy.
    Vitale C; Maglio A; Pelaia C; Vatrella A
    Expert Opin Pharmacother; 2017 May; 18(7):667-676. PubMed ID: 28387160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal comparison of outcomes in patients with smoking-related asthma-COPD overlap and in non-smoking asthmatics with incomplete reversibility of airway obstruction.
    Boulet LP; Boulay ME; Milot J; Lepage J; Bilodeau L; Maltais F
    Int J Chron Obstruct Pulmon Dis; 2019; 14():493-498. PubMed ID: 30880939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asthma-COPD Overlap Phenotypes and Smoking :Comparative features of asthma in smoking or non-smoking patients with an incomplete reversibility of airway obstruction.
    Boulet LP; Boulay MÈ; Dérival JL; Milot J; Lepage J; Bilodeau L; Maltais F
    COPD; 2018 Apr; 15(2):130-138. PubMed ID: 29683758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of asthma exacerbations and preventive strategies.
    Graham LM; Eid N
    Curr Med Res Opin; 2015 Apr; 31(4):825-35. PubMed ID: 25530129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscarinic Receptor Antagonists.
    Matera MG; Cazzola M
    Handb Exp Pharmacol; 2017; 237():41-62. PubMed ID: 27787709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.
    Buhl R; Farmer SG
    Proc Am Thorac Soc; 2004; 1(2):136-42. PubMed ID: 16113426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis.
    Sin DD; Man J; Sharpe H; Gan WQ; Man SF
    JAMA; 2004 Jul; 292(3):367-76. PubMed ID: 15265853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Executive summary: Japanese guidelines for adult asthma (JGL) 2021.
    Niimi A; Fukunaga K; Taniguchi M; Nakamura Y; Tagaya E; Horiguchi T; Yokoyama A; Yamaguchi M; Nagata M
    Allergol Int; 2023 Apr; 72(2):207-226. PubMed ID: 36959028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common lung conditions: chronic obstructive pulmonary disease.
    Delzell JE
    FP Essent; 2013 Jun; 409():23-31. PubMed ID: 23767419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of the Asthma-COPD Overlap Syndrome (ACOS): a Review of the Evidence.
    Hines KL; Peebles RS
    Curr Allergy Asthma Rep; 2017 Mar; 17(3):15. PubMed ID: 28283854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
    Prenner BM
    Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticosteroid-sparing options in the treatment of childhood asthma.
    Helms PJ
    Drugs; 2000; 59 Suppl 1():15-22; discussion 43-5. PubMed ID: 10741878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.